US Patent Issued to Ipsen Biopharm on Aug. 18 for "Treatment of brain damage" (British Inventor)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,661, issued on Aug. 18, was assigned to Ipsen Biopharm Ltd. (Wrexham, Great Britain).

"Treatment of brain damage" was invented by Mikhail Kalinichev (Wrexham, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a clostridial neurotoxin for use in a method of treating a brain disorder in a patient by promoting a neuroimmune response."

The patent was filed on Jan. 14, 2022, under Application No. 18/261,402.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND...